发明名称 Liver X receptor (LXR) modulators for the treatment of dermal diseases, disorders and conditions
摘要 Described herein are liver X receptor (LXR) modulators and methods of utilizing LXR modulators in the treatment of dermal diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
申请公布号 US8987318(B2) 申请公布日期 2015.03.24
申请号 US201414474490 申请日期 2014.09.02
申请人 Alexar Therapeutics, Inc. 发明人 Mohan Raju
分类号 C07D231/10;A61K31/4155;A61K31/415;C07D417/04;C07D413/04;C07D403/04;C07D409/04;C07D231/12;C07D405/04 主分类号 C07D231/10
代理机构 Fish & Richardson P.C. 代理人 Fish & Richardson P.C.
主权项 1. A compound of Formula (E):wherein: A and B are each nitrogen, wherein A and B are bonded together to form a five-membered heteroaryl ring; L1 is a bond, C1-C6alkyl, or C1-C6heteroalkyl; L2 is C1-C6alkyl or C1-C6heteroalkyl; R1 is hydrogen, halogen, —CF3, —OR8, —N(R8)2, —C(═O)R8, —C(═O)OR8, —C(═O)N(R8)2, —C(═N—OH)R8, —C(═S)N(R8)2, —C(═CH2)CH3, or —C(═O)OCH2SCH3; R2 is —C(═O)OR9, —C(═O)N(R9)2, —NR10C(═O)R9, —C(═N—OH)R9, —C(═S)N(R9)2, or —C(═O)OCH2SCH3; R3 is hydrogen, halogen, C1-C6alkyl, or C1-C6haloalkyl; R4 is aryl or heteroaryl; wherein aryl or heteroaryl is substituted with at least one R11; each R8, each R9, and each R10 are each independently hydrogen, C1-C6alkyl, C1-C6heteroalkyl, —C1-C6alkyl-aryl, aryl, or heteroaryl; each R11 is independently halogen, nitro, —OR10, —N(R10)2, —CN, —C(═O)R10, —C(═O)OR10, —C(═O)N(R10)2, —NR10C(═O)R10, NR10SO2R10, —SOR10, —SO2R10, —SO2N(R10)2, —C(═O)OCH2SCH3, C1-C6alkyl, C3-C8cycloalkyl, C1-C6haloalkyl, C1-C6heteroalkyl, —C1-C6alkyl-aryl, optionally substituted aryl, or optionally substituted heteroaryl;or a pharmaceutically acceptable salt or pharmaceutically acceptable solvate thereof.
地址 Malvern PA US